---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-019594"
form_type: "8-K"
ticker: "DCGO"
cik: "0001822359"
company_name: "DocGo Inc."
filed_at: "2023-03-13T23:59:59+00:00"
generated_at: "2026-06-18T04:46:05.929351+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# DocGo FY2022 revenue $440.5M (+38% YoY); guides 2023 revenue $500-$510M, Adj. EBITDA $45-50M

## Summary
- Full-year 2022 revenue $440.5M, up 38% YoY; net income $30.7M (+60%); Adjusted EBITDA $41.3M (+65%).
- Q4 revenue $108.8M vs $121.3M (Q4 2021 had $50M COVID revenue); transport revenue up 98% to $37M.
- 2023 guidance: revenue $500-510M (14-16% as-reported, 36-40% ex-COVID); Adj. EBITDA $45-50M; gross margin ~35%.
- Backlog of $180M over three years; 34 active RFPs totaling over $1B; $90M Citibank credit line unused.
- Since Jan 2023, awarded over $180M in new business across US and UK, including health system contracts; hiring hundreds, adding 100+ vehicles.

## SEC filing metadata
- accession: 0001213900-23-019594
- form_type: 8-K
- ticker: DCGO
- cik: 0001822359
- company_name: DocGo Inc.
- filed_at: 2023-03-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822359/000121390023019594/0001213900-23-019594-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822359/000121390023019594/ea175098-8k_docgoinc.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-019594
- JSON: https://secwatch.observer/filing/0001213900-23-019594.json
- Plain text: https://secwatch.observer/filing/0001213900-23-019594.txt

## Key facts
- Earnings Releases
  DocGo Inc. reported the fourth quarter ended December 31, 2022 results: revenue $108.8 million, net income $7.1 million.
  - Period: the fourth quarter ended December 31, 2022
  - Revenue: $108.8 million
  - Net income: $7.1 million
  - Result: reported results
  source text: Total Q4 2022 revenue was $108.8 million, which includes approximately $1 million of COVID testing revenue, compared to $121.3 million in Q4 2021
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822359/000121390023019594/0001213900-23-019594-index.htm
- Earnings Releases
  DocGo Inc. reported the year ended December 31, 2022 results: revenue $440.5 million, net income $30.7 million.
  - Period: the year ended December 31, 2022
  - Revenue: $440.5 million
  - Net income: $30.7 million
  - Result: reported results
  source text: PRESS RELEASE OF DOCGO INC. DATED MARCH 13, 2023 ANNOUNCING EARNINGS RELEASE Exhibit 99.1 DocGo Announces Fourth Quarter and Full-Year 2022 Results 2022 Revenue Increased to $440.5 Million, Versus $318.7 Million in 2021, an Increase of 38% Full Year Revenue up 75% Year-Over-Year Excluding Mass Covid Testing Company introduces Full-Year 2023 Revenue and Adjusted
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822359/000121390023019594/0001213900-23-019594-index.htm
- Earnings Releases
  DocGo Inc. updated its Full-Year 2023 guidance (initiated).
  - Period: Full-Year 2023
  - Guidance: initiated
  - Result: guidance update
  source text: Company introduces Full-Year 2023 Revenue and Adjusted EBITDA 1 Guidance of $500-$510 million and $45-$50 million, respectively
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822359/000121390023019594/0001213900-23-019594-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.